US 2020/0368273 A1Published application

Urine alkali agent useful for treatment of cancer patient

AssigneeDelta-Fly Pharma, Inc.

InventorsHiromi WADA, Kiyoshi ESHIMA, Tatsuhiro ISHIDA, Reo HAMAGUCHI

Life of this patent

Estimating the term…

Abstract

An object of the present invention is to provide a highly effective method for treatment/remission of cancer, and prevention of recurrence/metastasis of cancer at low cost and with few side effects. A composition containing a urinary alkalinization agent, for use in treatment or remission of cancer, or prevention of recurrence or metastasis of cancer.

Claims10

Dependent claims

-9. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 16/962,990Filed 22 Nov 2018
Priority: JP 2018-00730319 Jan 2018
Published: 26 Nov 2020
Term ends: Not estimatedThe source records don’t support an estimate.

Classification21 codes

A61K 33/00
Medicinal preparations containing inorganic active ingredients
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A23L 33/10
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof: using additives
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions

Family

US 11,622,976 B2Related patent
US 2020/0368273 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results